Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR1 | P21554 | 5/20 | 0.84 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.67 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.67 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.65 |
| ▸ | HPGD | P15428 | 2/20 | 0.65 |
| ▸ | SLC6A5 | Q9Y345 | 2/20 | 0.65 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.65 |
| ▸ | MEN1 | O00255 | 1/20 | 0.65 |
| ▸ | MAPT | P10636 | 1/20 | 0.65 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.65 |
| ▸ | BLM | P54132 | 1/20 | 0.65 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.65 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.65 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.62 |
| ▸ | LPAR1 | Q92633 | 1/20 | 0.62 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26044981 | 1.00 | CNR1 (0.84) | CNR1LPAR2EPHX2ALDH1A1HPGD | |
| SCHEMBL16619882 | 1.00 | CNR1 (0.84) | CNR1LPAR2EPHX2ALDH1A1HPGD | |
| SCHEMBL24474078 | 0.91 | CNR1 (1.00) | CNR1ALDH1A1HPGDSLC6A5TRPV1 | |
| SCHEMBL10802572 | 0.91 | EPHX2 (0.72) | CNR1LPAR2EPHX2ALDH1A1HPGD | |
| SCHEMBL1695972 | 0.91 | CNR1 (0.68) | CNR1LPAR2EPHX2MEN1KMT2A | |
| SCHEMBL1456865 | 0.91 | CNR1 (0.68) | CNR1LPAR2EPHX2MEN1KMT2A | |
| SCHEMBL1456478 | 0.91 | CNR1 (0.68) | CNR1LPAR2EPHX2MEN1KMT2A | |
| SCHEMBL5866922 | 0.91 | CNR1 (0.68) | CNR1LPAR2EPHX2MEN1KMT2A | |
| SCHEMBL17125686 | 0.89 | CNR1 (0.69) | CNR1LPAR2EPHX2HPGDMEN1 | |
| SCHEMBL9099462 | 0.88 | CNR1 (0.67) | CNR1LPAR2EPHX2ALDH1A1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160242443-A1 | Organic Compounds | GIVAUDAN S.A. (CH) | 2016-08-25 | — | — | US | claimed |
| EP-3057448-A1 | ORGANIC COMPOUNDS | Givaudan S.A. (CH) | 2016-08-24 | — | — | EP | claimed |
| WO-2015050534-A1 | ORGANIC COMPOUNDS | GIVAUDAN S.A. (CH) | 2015-04-09 | — | — | WO | claimed |
| US-10674755-B2 | Organic Compounds | GIVAUDAN S.A. (CH) | 2020-06-09 | — | — | US | disclosed |
| EP-3057448-B1 | ORGANIC COMPOUNDS HAVING TASTE-MODIFYING PROPERTIES | GIVAUDAN SA (CH) | 2017-12-06 | — | — | EP | disclosed |
| US-20160242443-A1 | Organic Compounds | GIVAUDAN S.A. (CH) | 2016-08-25 | — | — | US | disclosed |
| EP-3057448-A1 | ORGANIC COMPOUNDS | Givaudan S.A. (CH) | 2016-08-24 | — | — | EP | disclosed |
| WO-2015050534-A1 | ORGANIC COMPOUNDS | GIVAUDAN S.A. (CH) | 2015-04-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10674755-B2 | Organic Compounds | C9, PRMT5, CBR3 | CNR1 1503/4885LPAR2 4347/4885EPHX2 2845/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.